TP53 and rheumatoid arthritis: In in vitro studies, LLDT-8 could target activation of downstream E2F1 and p53 signaling through modulation of the lncRNA-WAKMAR2/miRNA-4478 axis, thereby suppressing proliferation, migration, and invasion of RA-FLS (31).